In:
Blood, American Society of Hematology, Vol. 134, No. 15 ( 2019-10-10), p. 1247-1256
Abstract:
211At targeted to CD38 eliminates MM cell clones in murine models of low-burden disease. 211At deposits ≥500 times more energy than β-emitters and provides a mechanism of uniform cell kill unique among MM therapeutics.
Type of Medium:
Online Resource
ISSN:
0006-4971
,
1528-0020
DOI:
10.1182/blood.2019001250
Language:
English
Publisher:
American Society of Hematology
Publication Date:
2019
detail.hit.zdb_id:
1468538-3
detail.hit.zdb_id:
80069-7